ACTA1 and Hepatic fibrosis: Moreover, ADSC-EVs carrying miR-223-3p were experimentally confirmed to confer hepatoprotection in vitro, corresponding to reduced contents of TG and TC as well as the expression of liver fibrosis markers α-SMA, COL1A1 and TGF-β1.